TC BioPharm (Holdings) (TC BioPharm (Holdings)) Ending Cash Position : $1.25 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is TC BioPharm (Holdings) Ending Cash Position?

TC BioPharm (Holdings)'s Ending Cash Position for the quarter that ended in Mar. 2024 was $1.25 Mil.

TC BioPharm (Holdings)'s quarterly Ending Cash Position declined from Jun. 2023 ($2.42 Mil) to Dec. 2023 ($0.00 Mil) but then increased from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($1.25 Mil).

TC BioPharm (Holdings)'s annual Ending Cash Position increased from Dec. 2021 ($2.08 Mil) to Dec. 2022 ($5.86 Mil) but then declined from Dec. 2022 ($5.86 Mil) to Dec. 2023 ($3.12 Mil).

TC BioPharm (Holdings) Ending Cash Position Historical Data

The historical data trend for TC BioPharm (Holdings)'s Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TC BioPharm (Holdings) Ending Cash Position Chart

TC BioPharm (Holdings) Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

1.25

1.01

2.08

5.86

3.12

TC BioPharm (Holdings) Quarterly Data
	Dec19	Sep20	Dec20	Jun21	Sep21	Dec21	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial							-	6.93	2.42	-	1.25

TC BioPharm (Holdings) Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

TC BioPharm (Holdings)'s Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6.088	+	-2.97
	=	3.12

TC BioPharm (Holdings)'s Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3.13	+	-1.883
	=	1.25

TC BioPharm (Holdings) Ending Cash Position Related Terms

Thank you for viewing the detailed overview of TC BioPharm (Holdings)'s Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

TC BioPharm (Holdings) (TC BioPharm (Holdings)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TC BioPharm (Holdings) PLC (NAS:TCBP) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

T0U:Germany

Address

Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR

Website

https://www.tcbiopharm.com

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Executives

Renaissance Capital Partners Ltd	10 percent owner	42 SHAD THAMES, LONDON X0 SE1 2YD
Diana Elizabeth Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Kenneth Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Mark Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD